We’re advancing ESG initiatives that contribute to our sustainable growth, so that we can create a positive impact for generations to come.
Our leaders are stewards of our environmental, social and governance (ESG) mission, and our people are committed to ensuring our research, innovations and collaborations put impact for people, communities and our world first.
We discover and deliver innovative medicines that solve serious health issues.
We unlock the full potential of our diverse and talented teams and partners to deliver today and into the future.
We innovate with integrity and intention to advance long-term patient health and business resiliency.
Our ESG Action Report details the progress we’ve made towards fulfilling our ESG commitments. Download our latest report to see what impact we made in 2023.
We periodically conduct materiality assessments to inform which environmental, social & governance (ESG) issues are most relevant to our business and our stakeholders. Reviewed and approved by executive leadership, we identified our material ESG topics by gathering and analyzing insights and feedback from a variety of internal and external stakeholders, including senior cross-functional leadership, employees, investors, community partners, patients, regulators and more.
We work to consistently discover and deliver innovative medicines that address serious health issues and enhance people’s lives.
We believe everyone who needs our medicines should be able to get them.
We are committed to delivering safe and effective products and medicines through robust quality systems.
We nurture diverse talent to solve the most complex health challenges and create a remarkable impact in people’s lives.
We continuously strive to improve health outcomes for patients around the world.
We act with integrity in everything we do.
We aim to reduce our environmental footprint and grow sustainability through inspiring innovation.
To ensure we're delivering on our commitments, we track and report our progress and continually evaluate our efforts relative to external frameworks such as the S&P Global Corporate Sustainability Assessment, CDP and the Sustainability Accounting Standards Board.
The product-specific site Internet site that you have requested is intended for the residents of a particular country or countries, as noted on that site. As a result, the site may contain information on pharmaceuticals that are not approved in other countries or region. If you are a resident of a country other than those to which the site is directed, please return to AbbVie.com or contact your local AbbVie affiliate to obtain the appropriate product information for your country of residence. The Internet site that you have requested may not be optimized to your screen size. Do you wish to continue to this product-specific site?